Hepion Pharmaceuticals (HEPA) Earnings Date & Reports

A.I. Advisor
published Earnings

HEPA is expected to report earnings to rise 61.11% to -290 cents per share on May 16

Hepion Pharmaceuticals HEPA Stock Earnings Reports
Q1'23
Est.
$-2.90
Q4'22
Missed
by $1.68
Q3'22
Beat
by $0.06
Q2'22
Missed
by $4.94
Q1'22
Est.
$-0.09
The last earnings report on March 01 showed earnings per share of -179 cents, missing the estimate of -11 cents. With 30.64K shares outstanding, the current market capitalization sits at 6.06M.
View a ticker or compare two or three
HEPA
Daily Signal changed days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a pharmaceutical company, which engages in the development and commercialization of pleiotropic drug therapy for the treatment of chronic liver disease

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
399 Thornall Street
Phone
+1 732 902-4000
Employees
25
Web
https://www.hepionpharma.com